AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
Testicular cancer
Authors: Oliver, RTD
Citation: Rtd. Oliver, Testicular cancer, CURR OPIN O, 13(3), 2001, pp. 191-198
Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study
Authors: Shamash, J McLaren, B LeVay, JH Ong, J Murray, P Asterling, S Oliver, RTD
Citation: J. Shamash et al., Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study, CANC CHEMOT, 47(4), 2001, pp. 370-372
Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy?
Authors: Berney, DM Shamash, J Pieroni, K Oliver, RTD
Citation: Dm. Berney et al., Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy?, HISTOPATHOL, 39(4), 2001, pp. 382-385
The characterisation of the lymphoma cell line U937, using comparative genomic hybridisation and multi-plex FISH
Authors: Strefford, JC Foot, NJ Chaplin, T Neat, MJ Oliver, RTD Young, BD Jones, LK
Citation: Jc. Strefford et al., The characterisation of the lymphoma cell line U937, using comparative genomic hybridisation and multi-plex FISH, CYTOG C GEN, 94(1-2), 2001, pp. 9-14
Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line
Authors: Torabi-Pour, N Nouri, AME Perrett, D Oliver, RTD
Citation: N. Torabi-pour et al., Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line, BIOMED CHRO, 15(1), 2001, pp. 18-24
The use of multicolor fluorescence technologies in the characterization ofprostate carcinoma cell lines: a comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data
Authors: Strefford, JC Lillington, DM Young, BD Oliver, RTD
Citation: Jc. Strefford et al., The use of multicolor fluorescence technologies in the characterization ofprostate carcinoma cell lines: a comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data, CANC GENET, 124(2), 2001, pp. 112-121
Computed tomography 21 days after chemotherapy, three-dimensional estimates of metastatic volume and the need for surgery in patients with germ cell cancer
Authors: Bozcuk, HS Ravi, R Turner, B Tsetis, D Thomas, JM Chan, O Reznek, R Hendry, WF Oliver, RTD
Citation: Hs. Bozcuk et al., Computed tomography 21 days after chemotherapy, three-dimensional estimates of metastatic volume and the need for surgery in patients with germ cell cancer, BJU INT, 86(6), 2000, pp. 707-713
Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomy
Authors: Farrugia, D Ansell, W Singh, M Philp, T Chinegwundoh, F Oliver, RTD
Citation: D. Farrugia et al., Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomy, BJU INT, 85(9), 2000, pp. 1069-1073
Renal cell carcinoma presenting with cardiac failure
Authors: Piggott, M Farrugia, D Otite, U Oliver, RTD Crake, T
Citation: M. Piggott et al., Renal cell carcinoma presenting with cardiac failure, HOSP MED, 61(11), 2000, pp. 804-805
Potential of intermittent hormone therapy for M+ and M0 prostate cancer patients
Authors: Oliver, RTD Farrugia, D Ansell, W Willams, G Chinegwundoh, F
Citation: Rtd. Oliver et al., Potential of intermittent hormone therapy for M+ and M0 prostate cancer patients, PROSTATE C, 3(4), 2000, pp. 286-289
Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer
Authors: Feneley, MR Jan, H Granowska, M Mather, SJ Ellison, D Glass, J Coptcoat, M Kirby, RS Ogden, C Oliver, RTD Badenoch, DF Chinegwundoh, FI Nargund, VH Paris, AMI Britton, KE
Citation: Mr. Feneley et al., Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer, PROSTATE C, 3(1), 2000, pp. 47-52
Testosterone - Its role in development of prostate cancer and potential risk from use as hormone replacement therapy
Authors: Slater, S Oliver, RTD
Citation: S. Slater et Rtd. Oliver, Testosterone - Its role in development of prostate cancer and potential risk from use as hormone replacement therapy, DRUG AGING, 17(6), 2000, pp. 431-439
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours
Authors: Rapley, EA Crockford, GP Teare, D Biggs, P Seal, S Barfoot, R Edwards, S Hamoudi, R Heimdal, K Fossa, SD Tucker, K Donald, J Collins, F Friedlander, M Hogg, D Goss, P Heidenreich, A Ormiston, W Daly, PA Forman, D Oliver, RTD Leahy, M Huddart, R Cooper, CS Bodmer, JG Easton, DF Stratton, MR Bishop, DT
Citation: Ea. Rapley et al., Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours, NAT GENET, 24(2), 2000, pp. 197-200
Current opinion in germ cell cancer 2000
Authors: Oliver, RTD
Citation: Rtd. Oliver, Current opinion in germ cell cancer 2000, CURR OPIN O, 12(3), 2000, pp. 249-254
Concordance between tumour cell activation by epidermal growth factor and alteration of cell sensitivity to cisplatin and lymphokine-activated killercell activity
Authors: Nouri, AME Zubairi, ST Russell, MV Moss, T Cannell, H Paris, AMI Symes, M Oliver, RTD
Citation: Ame. Nouri et al., Concordance between tumour cell activation by epidermal growth factor and alteration of cell sensitivity to cisplatin and lymphokine-activated killercell activity, ONCOL REP, 7(1), 2000, pp. 197-201
Male circumcision and HIV prevention - More studies need to be done beforewidespread circumcision is implemented
Authors: Oliver, RTD Oliver, J Ballard, RC
Citation: Rtd. Oliver et al., Male circumcision and HIV prevention - More studies need to be done beforewidespread circumcision is implemented, BR MED J, 321(7274), 2000, pp. 1468-1469
Management of women with early breast cancer - New strategies are needed to address inequalities
Authors: Oliver, RTD
Citation: Rtd. Oliver, Management of women with early breast cancer - New strategies are needed to address inequalities, BR MED J, 321(7273), 2000, pp. 1409-1409
Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?
Authors: Shamash, J O'Doherty, CA Oliver, RTD Kelsey, S Gupta, RK Gallagher, CJ Newland, AC Lister, TA
Citation: J. Shamash et al., Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?, ACTA ONCOL, 39(7), 2000, pp. 857-863
The combined use of high performance liquid chromatography and immuno-biochemical techniques for protein isolation: a new approach for identificationof an individual protein from a pool of proteins
Authors: Torabi-Pour, N Nouri, AME Perrett, D Oliver, RTD
Citation: N. Torabi-pour et al., The combined use of high performance liquid chromatography and immuno-biochemical techniques for protein isolation: a new approach for identificationof an individual protein from a pool of proteins, BIOMED CHRO, 14(7), 2000, pp. 483-488
Advanced testicular cancer presenting with phlegmasia cerulea dolens
Authors: Mulatero, C Brogan, G Oliver, RTD
Citation: C. Mulatero et al., Advanced testicular cancer presenting with phlegmasia cerulea dolens, POSTG MED J, 76(894), 2000, pp. 234-236
Though HIV is the main cause of AIDS, other factors play a role
Authors: Oliver, RTD
Citation: Rtd. Oliver, Though HIV is the main cause of AIDS, other factors play a role, NATURE, 406(6797), 2000, pp. 673-673
CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size
Authors: Sohaib, SA Turner, B Hanson, JA Farquharson, M Oliver, RTD Reznek, RH
Citation: Sa. Sohaib et al., CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size, BR J RADIOL, 73(875), 2000, pp. 1178-1184
Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma
Authors: Mulatero, C McClaren, BR Mason, M Oliver, RTD Gallagher, CJ
Citation: C. Mulatero et al., Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma, BR J CANC, 83(12), 2000, pp. 1612-1616
A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
Authors: Horwich, A Oliver, RTD Wilkinson, PM Mead, GM Harland, SJ Cullen, MH Roberts, JT Fossa, SD Dearnaley, DP Lallemand, E Stenning, SP
Citation: A. Horwich et al., A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma, BR J CANC, 83(12), 2000, pp. 1623-1629
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
Authors: Shamash, J Oliver, RTD Gallagher, CJ Newland, AC Lister, TA Kelsey, S Gupta, RK O'Doherty, CA
Citation: J. Shamash et al., Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy, BR J CANC, 82(12), 2000, pp. 2022-2023
Risultati: 1-25 | 26-34